Compare CELU & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CELU | MATH |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | Hong Kong |
| Employees | 123 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 52.1M |
| IPO Year | N/A | 2016 |
| Metric | CELU | MATH |
|---|---|---|
| Price | $1.31 | $1.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 75.4K | 68.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | ★ N/A | $3.10 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $1.10 |
| 52 Week High | $4.35 | $4.17 |
| Indicator | CELU | MATH |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 40.28 |
| Support Level | $1.21 | $1.10 |
| Resistance Level | $1.33 | $3.16 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 61.10 | 73.68 |
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.